ADMA Biologics (ADMA) has had the highest return between 2022 and 2024 by a mid-cap US stock, returning 1,143.6%.

ASSET	YEARS	% RETURN
ADMA Biologics (ADMA)	2022-2024	1,143.57%
Modine Manufacturing (MOD)	2022-2024	1,059.14%
Vista Oil Gas ADR (VIST)	2022-2024	918.87%
Banco Macro SA B ADR (BMA)	2022-2024	827.63%
Viking Therapeutics (VKTX)	2022-2024	806.85%
Powell Industries (POWL)	2022-2024	740.63%
BBVA Banco Frances SA ADR (BBAR)	2022-2024	725.7%
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN)	2022-2024	725.36%
Verona Pharma PLC ADR (VRNA)	2022-2024	563.33%
Sterling Construction (STRL)	2022-2024	558.72%
Transportadora de Gas del Sur SA ADR (TGS)	2022-2024	543.18%
Carpenter Technology (CRS)	2022-2024	519.66%
Biohaven Pharmaceutical (BHVN)	2022-2024	495.83%
Rhythm Pharmaceuticals (RYTM)	2022-2024	458.5%
Central Puerto (CEPU)	2022-2024	443.12%
MoonLake Immunotherapeutics (MLTX)	2022-2024	432.02%
United States Lime & Minerals (USLM)	2022-2024	428.73%
Consol Energy (CEIX)	2022-2024	390.14%
Tidewater (TDW)	2022-2024	368.6%
Nuvalent (NUVL)	2022-2024	345.79%
F&G Annuities & Life (FG)	2022-2024	343.77%
Abercrombie & Fitch (ANF)	2022-2024	332.02%
Wave Life Sciences (WVE)	2022-2024	328.43%
Hims Hers Health (HIMS)	2022-2024	327.81%
Torm PLC Class A (TRMD)	2022-2024	323.64%

Mid-cap stocks are treated as having a market cap between $2B and $10B.